Bombay HC to Large Corporates: Adopt Reasonable Litigation Policies, Don't Bankrupt MSMEs

In a sternly worded judgment, the Bombay High Court has called upon large corporations to exercise litigation restraint and adopt fair policies when dealing with smaller enterprises, emphasizing that the protective measures in the MSMED Act are not to be treated as "mere miscellaneous expenses."

In a significant ruling that reinforces the protective ambit of the Micro, Small and Medium Enterprises Development (MSMED) Act, 2006, the Bombay High Court has dismissed an appeal filed by Mahindra Defence Systems Ltd. against an arbitral award favouring Ranjana Industries, an MSME. Justice Somasekhar Sundaresan, while upholding the award, delivered a powerful message to India's corporate leaders, urging them to introspect on their litigation strategies and avoid dragging smaller entities into protracted and potentially ruinous legal battles.

The Court's decision in Mahindra Defence Systems Limited v. Ranjana Industries not only reaffirms the limited scope of judicial interference in arbitral awards under Sections 34 and 37 of the Arbitration and Conciliation Act, 1996 but also provides a crucial interpretation of key provisions within the MSMED Act, particularly the mandatory nature of timelines for raising objections to supplied goods.

---

Background of the Dispute

The genesis of the dispute lies in three purchase orders from Mahindra Defence Systems Ltd. (the Appellant) to Ranjana Industries (the Respondent), a sole proprietorship, for the supply of "QTTM Assembly Section" components. While Mahindra made part payments, it withheld outstanding dues, prompting Ranjana Industries to seek recourse through the Micro, Small and Medium Enterprises Facilitation Council. The Respondent claimed the principal amount along with the high-rate of compound interest stipulated under Sections 15 and 16 of the MSMED Act for delayed payments.

In its defence, Mahindra contended that the dispute was not merely about non-payment but stemmed from delayed and defective delivery of goods that failed to meet technical specifications. It also belatedly argued that the agreement was a "work contract," which it claimed fell outside the purview of the MSMED Act.

The MSME Facilitation Council, acting as the arbitral tribunal, ruled in favour of Ranjana Industries. This award was subsequently challenged by Mahindra under Section 34 of the Arbitration Act before the District Judge, who upheld the Council's decision. Undeterred, Mahindra escalated the matter to the Bombay High Court through an appeal under Section 37 of the Arbitration Act.

High Court's Findings: A Masterclass on Judicial Restraint and Statutory Intent

Justice Sundaresan’s judgment systematically dismantled the grounds of appeal, focusing on the core principles of arbitral law and the specific legislative intent behind the MSMED Act.

1. Limited Scope of Interference under Arbitration Act

The Court began by reiterating the established legal position that judicial review of an arbitral award is extremely narrow. The bench observed that Mahindra’s appeal was essentially a request for a "merit-based second appeal," seeking a complete re-appreciation of the evidence presented before the Council. This, the Court stressed, is impermissible under Sections 34 and 37 of the Arbitration Act. The judicial mandate is to check for patent illegality or perversity, not to substitute its own view for that of the arbitrator, especially when the arbitrator's conclusion is a plausible one based on the evidence on record.

2. The Mandatory Nature of the 'Appointed Day'

A crucial aspect of the ruling was the Court's interpretation of the MSMED Act's timeline for raising objections. Mahindra's objections regarding defects were raised well after the delivery of goods. The Court delved into the definition of the "appointed day" under Section 2(e) of the Act, which sets a 15-day mandatory period from the date of delivery for the buyer to raise any objections in writing.

Justice Sundaresan held that this 15-day window is not merely directory but mandatory. He explained the cascading effect of this provision:

“The definition of 'appointed day' has firm and specific consequences under the Act — it determines when payment becomes due, when interest starts accruing, and when statutory disclosures must be made. It cannot be lightly wished away.”

The Court found that Mahindra's communications, sent after this period, were not valid objections but "mere observations for improvement." Consequently, the payment became due upon the expiry of the "appointed day," and the tribunal was correct in its finding.

3. The Plausibility Test and Lack of Evidence

The High Court noted that the arbitral tribunal had arrived at its conclusions based on a plausible interpretation of the evidence. Mahindra had failed to provide concrete proof to substantiate its claims of defective goods. The Court pointed out several evidentiary gaps: * There was no proof that the allegedly defective goods were ever returned to Ranjana Industries. The tribunal could plausibly conclude that Mahindra had put the components to use. * Mahindra provided no evidence of having paid any liquidated damages or penalties to its ultimate customer, the Government of India, for the alleged defects. * The claim of engaging an alternate vendor was supported by nothing more than a purchase order, with no corresponding proof of performance, payment, or even VAT filings to show the transaction was completed.

Given these deficiencies, the Court held that the tribunal's decision was fair, reasoned, and free from perversity.

4. The 'Work Contract' Argument Dismissed

The Court also summarily dismissed Mahindra’s belated argument that the agreement was a "work contract" and thus outside the MSMED Act's scope. It affirmed the lower court's finding that the contract was for the supply of goods and services, placing it squarely within the jurisdiction of the Act.

A Broader Message to Corporate India

Beyond the legal technicalities, the judgment’s true impact lies in its powerful obiter dicta directed at corporate litigation culture. Justice Sundaresan articulated a clear expectation for industry leaders to act as exemplars of fair play.

“Large corporates, particularly those that occupy positions of corporate leadership, must set an example by adopting a reasonable litigation policy. For the weak protectees of the MSMED Act, non-payment and continued frustration could lead to bankruptcy.”

The Court reminded large entities that the stringent provisions of the MSMED Act, such as the deterrent interest rate under Section 16 and the requirement to deposit 75% of the awarded amount before filing an appeal under Section 19, are designed with a clear social and economic purpose.

“Large corporates must introspect on what battles to pick and litigate on. The deterrent interest rate under Section 16 and the 75% deposit requirement under Section 19 of the MSMED Act are meant to protect micro enterprises, not to be treated as mere miscellaneous expenses.”

Implications for Legal Professionals and the Industry

This judgment serves as a critical precedent and a practical guide for legal practitioners advising both large corporations and MSMEs. * For counsels of large corporations: It underscores the futility of challenging arbitral awards on grounds that amount to a re-evaluation of evidence. The focus must be on demonstrating patent illegality or perversity, a very high threshold. Furthermore, it highlights the critical importance of adhering to statutory timelines, such as the 15-day objection period under the MSMED Act, and maintaining meticulous documentation to support any claims of defect or non-performance. * For advocates representing MSMEs: The ruling reinforces the strength of the protective framework of the MSMED Act. It validates the authority of the Facilitation Council and provides strong ammunition to counter attempts by larger entities to delay payments through prolonged litigation. * For the arbitration community: It solidifies the principle of minimal judicial intervention and respects the finality of arbitral awards, especially those emerging from specialized statutory tribunals like the MSME Council.

By dismissing the appeal, the Bombay High Court has sent an unequivocal message: the judiciary will robustly defend the legislative intent behind protective statutes like the MSMED Act and will not permit the legal process to be used as a tool to exhaust smaller players in the economic ecosystem. It is a call for a more conscientious and responsible approach to corporate litigation.

---

Case Title: Mahindra Defence Systems Limited Versus Ranjana Industries Through Sole Prop. Mr. Sunil Palve Case Number: ARBITRATION APPEAL NO. 47 OF 2023